These findings suggest that the anti-metastatic effects of ArcA in melanoma cells are attributed to the dephosphorylation of GSK-3β at Ser9, along with the subsequent reduction in MMP-9 and MMP-13 levels. Here, MMP9 is linked to melanoma.